Cargando…
Reactivation of mutant p53 in esophageal squamous cell carcinoma by isothiocyanate inhibits tumor growth
p53 mutations are prevalent in human cancers; approximately half of patients with esophageal cancer present these mutations. Mutant p53 (mutp53) exerts oncogenic functions that promote malignant tumor progression, invasion, metastasis, and drug resistance, resulting in poor prognosis. Some small mol...
Autores principales: | Guan, Lulu, Yang, Yalan, Lu, Yao, Chen, Yu, Luo, Xi, Xin, Dao, Meng, Xiangrui, Shan, Zhengzheng, Jiang, Guozhong, Wang, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164965/ https://www.ncbi.nlm.nih.gov/pubmed/37168998 http://dx.doi.org/10.3389/fphar.2023.1141420 |
Ejemplares similares
-
A Novel Predictor of Pathologic Complete Response for Neoadjuvant Immunochemotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
por: Yang, Yalan, et al.
Publicado: (2023) -
Reactivation of mutant p53 by a dietary-related compound phenethyl isothiocyanate inhibits tumor growth
por: Aggarwal, M, et al.
Publicado: (2016) -
Editorial: Metabolic and Neurological Modulation by Glucosinolates, Isothiocyanates, and Terpenes to Improve Health
por: González-Trujano, M. E., et al.
Publicado: (2022) -
Small molecule induced reactivation of mutant p53 in cancer cells
por: Liu, Xiangrui, et al.
Publicado: (2013) -
Targeting mutant p53 stabilization for cancer therapy
por: Wang, Jiajian, et al.
Publicado: (2023)